期刊文献+

癌性神经痛动物模型的制备 被引量:1

下载PDF
导出
摘要 癌性疼痛为临床上最为常见、最难治疗的慢性疼痛之一。在癌性疼痛的分类中,癌性神经痛的诊治是临床上较为棘手的问题。为研究癌性神经痛的发病机制和探索新的治疗方法,目前已经制备出许多动物模型。本文旨在介绍癌性神经痛动物模型的制备和研究现状。
出处 《中国疼痛医学杂志》 CAS CSCD 2011年第8期450-453,共4页 Chinese Journal of Pain Medicine
  • 相关文献

参考文献18

  • 1神经病理性疼痛诊治专家共识[J].中华内科杂志,2009,48(6):526-528. 被引量:38
  • 2毛庆祥,杨天德.神经病理性疼痛动物模型[J].中国医药指南(学术版),2008,6(6):13-14. 被引量:9
  • 3Honore P, Rogers SD, Schwei M J, et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience,2000,98 : 585 - 598.
  • 4Kehl LJ, Hamamoto DT, Wacnik PW, et al. A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain,20 03,103 : 175 186.
  • 5Luger NM, Sabino MAC, Schwei M J, et al. Efficacy of systemic morphine suggests a fu ndamental difference in the mechanisms that generate bone cancer vs. inflammatory pain. Pain,2002,99: 397-406.
  • 6Honore P, Luger NM, Sabino MAC,et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nature Med, 2000,6 : 521 -528.
  • 7Luger NM, Honore P, Sabino MAC,et al. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res,2001,61 : 4038 -4047.
  • 8Cavaletti G,Tredici G, Braga M,et al. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurology,1995,133 : 64 -72.
  • 9Flatters S J, Bennett GJ. Ethosuximide reverses paclitaxel and vincristine-induced painful peripheral neuropathy. Pain,2004,109 : 150 - 161.
  • 10Authier N, Gillet JP, Fialip J, et al. Description of a short-term taxol-induced nociceptive neuropathy in rats. Brain Res,2000,887 : 239 - 249.

二级参考文献17

  • 1Merskey H, Bogduk N//Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Task force on taxonomy of the international association for the study of pain. 2nd ed. Seattle: IASP Press, 1994.
  • 2Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neuro l,2003,60 : 1524-1534.
  • 3Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neural,2004, 1 : 153-162.
  • 4Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology,1997,48:332-338.
  • 5Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain, 1975,1:277-299.
  • 6Melzack R. The short-form McGill Pain Questionnaire. Pain, 1987,30 : 191-197.
  • 7Garcia-Larrea L, Convers P, Magnin M, et al. Laser-evoked potential abnormalities in central pain patients: the influence of spontaneous and provoked pain. Brain, 2002,125 (Pt 12) :2766- 2781.
  • 8Moisset X, Bouhassira D. Brain imaging of neuropathic pain. Neuroimage ,2007,37 Suppl 1 : S80-88.
  • 9Attal N, Cruccu G, HaanpaaM, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol, 2006,13 : 1153-1169.
  • 10Finnerup NB, Otto M, McQuay H J, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain, 2005,118 : 289 -305.

共引文献45

同被引文献16

  • 1Park SB, Lin CS, Krishnan AV, et al. Early, progressive, and sus tained dysfunction of sensory axons underlies paclitaxel induced neu ropathy[J]. Muscle Nerve,2011,43(3) :367 374.
  • 2Anastassiou E,Iatrou CA,Vlaikidis N,et al. Impact of pregaba lin treatment on pain,pain-related sleep interference and genera well-being in patients with neuropathie pain:a non-intervention al, multieentre, post-marketing study [J] . Clin Drug Investig 2011,31(6) :417-426.
  • 3Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neu rotoxicity[J]. Nat Rev Neurol,2010,6(12) :657-666.
  • 4Zimmemaann M. Ethical guidelines for investigations of experimental pain in conscious animals[J]. Pain,1983,16(2):109-110.
  • 5Pinkel D. The use of body sur{ace area as a criterion of drug dosage in cancer chemotherapy[J]. Cancer Res,1958,18(7):853-856.
  • 6Meng X,Zhang Y,Li A,et al. The effects of opioid receptor an tagonists on electroacupuneture-produced anti-allodynia/hyperal gesia in rats with paclitaxel-evoked peripheral neuropathy[J] Brain Res,2011,1414(26) 58-65.
  • 7Wang Y,Li X,Cao L,et al. Analgesic effect of diprospan in rats with trigeminal neuralgia[J]. J Huazhong Univ Sci Technolog Med Sci,2011,31(3) :395-399.
  • 8Hargreaves K,Dubner R,Brown F,et al. A new and sensitive meth od for measuring thermal noeiception in cutaneous hyperalgesia[J]. Pain, 1988,32(1) :77-88.
  • 9Choi Y, Yoon YW, Na HS, et al. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain[J]. Pain, 1994,59(3) =369-376.
  • 10Persohn E,Canta A,Schoepfer S,et al. Morphological and morpho- metric analysis of paclitaxel and docetaxel-induced peripheral neurop- athy in rats[J]J. Eur J Cancer,2005,41(10):1460-1466.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部